3 transcripts
BTMD
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
to enhance our long-term growth opportunities. These investments included our annual provider conference where we strengthen engagement with our top
BTMD
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
. We successfully launched BioteRx, our new suite of complementary hormone and evidence-based wellness products, greatly expanding our long-term growth
BTMD
Earnings call transcript
NASDAQ
2023 Q4
12 Mar 24
share repurchase program, further reflecting our commitment to enhancing long-term shareholder value. We began to execute against this program early
- Prev
- 1
- Next